Am I in Perimenopause?

What this screener tells you

Perimenopause is the 4-to-10-year transition that precedes menopause. During this window, estrogen and progesterone shifts disrupt the menstrual cycle and drive a cluster of symptoms that affect sleep, cognition, mood, cardiovascular function, and bone. Menopause itself is defined as 12 consecutive months without a menstrual period — everything before that point is perimenopause, and everything after is post-menopause. Most of the disruptive symptoms women associate with "the change" actually happen during perimenopause, often years before periods stop.

The Menopause Rating Scale (MRS) is an 11-item validated symptom instrument originally developed by Heinemann and colleagues. It is in the public domain and is used internationally to quantify symptom burden across somatic, psychological, and urogenital domains. This screener maps your responses against MRS-validated severity tiers so you have a calibrated read on whether your symptoms are mild, moderate, severe, or extremely severe.

What this screener does: it tells you where your reported symptom burden lands on a validated scale and whether a clinical conversation is warranted. What it does not do: it does not diagnose perimenopause, it does not prescribe anything, and it does not replace a clinician.

Why an in-person clinic in Park Ridge

Many online perimenopause services are video-only and skip the in-person exam, same-day lab draw, and comprehensive panel — the parts that drive a good clinical decision for some patients.

Moonshot Medical is a real bricks-and-mortar clinic in Park Ridge, Illinois. We see you in person. We run a 60-plus marker comprehensive panel — not a four-marker hormone screen — so we can rule out the things that mimic perimenopause (thyroid disease, anemia, vitamin and mineral deficiencies, insulin resistance, sleep apnea risk markers) before attributing everything to hormones. And because you are in the room, we can do real exam steps that matter for women's health screening rather than punting them to "your primary."

If the screener flags meaningful symptom burden, the next step is a structured intake visit with full labs. Local. Real. Same building.

What the screener checks

The 11 MRS symptom domains, in plain English:

• Hot flushes and sweating. The classic vasomotor symptom — sudden waves of heat, often with sweating, day or night.
• Heart discomfort. Palpitations, racing heart, skipped beats, or a sense of pressure in the chest.
• Sleep problems. Difficulty falling asleep, staying asleep, or waking too early.
• Depressive mood. Feeling down, sad, on the verge of tears, or losing motivation.
• Irritability. Feeling tense, easily set off, or aggressive.
• Anxiety. Inner restlessness, feeling panicky, or a sense of dread.
• Physical and mental exhaustion. Drop in performance, memory lapses, decreased concentration, forgetfulness.
• Sexual problems. Change in libido, sexual activity, or sexual satisfaction.
• Bladder problems. Difficulty urinating, urgency, increased frequency, or incontinence.
• Vaginal dryness. Sensation of dryness or burning, discomfort with intercourse.
• Joint and muscular discomfort. Joint pain, rheumatic-type complaints, muscle aches.

In addition to the MRS domains, the screener includes a contraindication safety screen: history of blood clots (DVT/PE), hormone-sensitive cancers, severe liver disease, recent stroke or TIA, coronary artery disease or heart attack, uncontrolled hypertension, migraine with aura, unexplained vaginal bleeding, and pregnancy. These categories come from FDA labeling for hormone-based therapies. Clinicians screen for them before any conversation about hormone-based options because they directly determine which treatments are on or off the table.

Common questions

How is perimenopause different from menopause?

Perimenopause is the multi-year transition leading up to menopause, typically lasting 4 to 10 years. During perimenopause, hormone levels fluctuate and periods become irregular, but you are still cycling. Menopause itself is a single point in time — defined as 12 consecutive months without a menstrual period. Everything after that point is post-menopause. Most of the disruptive symptoms — hot flushes, sleep loss, mood changes, brain fog — start in perimenopause, often years before periods stop entirely.

Do I have to be a certain age to be in perimenopause?

No. The average age of menopause in the United States is around 51, which means perimenopause commonly starts in the early-to-mid 40s, but it can begin earlier. Women in their late 30s can experience perimenopausal symptoms, and women whose menopause was triggered surgically or medically can experience the same symptom pattern at any age. Symptom burden — not the number on your driver's license — is what matters clinically.

What's the difference between this screener and a real diagnosis?

This screener is a validated symptom questionnaire, not a diagnosis. It tells you how your reported symptom burden compares to MRS-defined severity tiers. A real clinical evaluation includes a focused history, a physical exam, and lab work — at Moonshot Medical that means a 60-plus marker comprehensive panel, not a four-marker hormone screen. Use the screener as a triage tool to decide whether a clinical visit is worth your time.

If my symptoms are severe, do I have to take HRT?

No. Severe symptoms mean it is worth a structured clinical conversation, but treatment is always a shared decision. Options span lifestyle interventions (sleep, strength training, nutrition, alcohol reduction), non-hormone-based options that target specific symptoms like vasomotor flushes or sleep, and hormone-based options when appropriate and not contraindicated. The right plan depends on your symptom pattern, medical history, personal goals, and risk tolerance — not a default protocol.

Why does the screener ask about history of blood clots and cancer?

Because those histories matter for which treatment options are even on the table. FDA labeling for hormone-based therapies lists specific contraindication categories — history of clots, hormone-sensitive cancers, severe liver disease, recent stroke or TIA, coronary artery disease, uncontrolled hypertension, migraine with aura, unexplained vaginal bleeding, and pregnancy. Asking up front lets a clinician steer the conversation toward the safest evidence-based options for you and avoid wasted visits.

Related screeners and reading

• Bone density screener — estrogen drop accelerates bone loss, so this is the natural sibling quiz to take next.
• Women's hormone care — service overview, what's included, and how to book.
• Menopause vs. perimenopause — the timeline, symptom pattern, and what changes when.
• The WHI study and what HRT actually shows — context for the headlines and how the data has aged.
• BHRT cost — typical pricing, what insurance covers, and cash-pay options.